1 |
Im SA, Lee DW, Kang R, Kim JH, Kim DW, Jang IJ, et al. Challenges and insights of early oncology drug development in the Asia-Pacific region: introduction of phase I oncology clinical trial center and experience sharing for early clinical trials in Seoul National University Hospital, Korea. Chinese Clinical Oncology.2019;8(3):27.
DOI
|
2 |
Unger JM, Cook E, Tai E, Bleyer A. The role of clinical trial participation in cancer research: barriers, evidence, and strategies. American Society of Clinical Oncology educational book. 2016;36(36):185-98.
DOI
|
3 |
Moon TJ. Light and shadows of the Korean healthcare system. Journal of Korean Medical Science. 2012;27(Suppl):S3-S6.
DOI
|
4 |
Scoggins JF, Ramsey SD. A national cancer clinical trials system for the 21st century: reinvigorating the NCI cooperative group program. Journal of the National Cancer Institute. 2010;102(17):1371.
DOI
|
5 |
Lim Y, Lim JM, Jeong WJ, Lee KH, Keam B, Kim TY, et al. Korean cancer patients' awareness of clinical trials, perceptions on the benefit and willingness to participate. Cancer Research and Treatment. 2017;49(4):1033-43.
DOI
|
6 |
Jeong HS, Lee KS, Chee HK, Ahn HM, Sim SB. Thoracic and cardiovascular surgeons' perception of the concentration of cardiovascular operations in Seoul metropolitan area's hospitals. Korean Journal of Thoracic and Cardiovascular Surgery. 2016;49:53-9.
DOI
|
7 |
Shim BY, Park SH, Lee S, Kim JS, Lee KE, Kang YK, et al. Current status and challenges of cancer clinical trials in Korea. Cancer Research and Treatment. 2016;48(1):20-7.
DOI
|
8 |
Lee SJ, Park LC, Lee J, Kim S, Choi MK, Hong JY, et al. Unique perception of clinical trials by Korean cancer patients. BioMed Central Cancer. 2012;12(1):594.
|
9 |
Chee DH. Korean clinical trials: its current status, future prospects, and enabling environment. Translational and Clinical Pharmacology. 2019;27(4):115-8.
DOI
|
10 |
Frost & Sullivan. Asia: Preferred Destination for Clinical Trials 2020. Santa Clara, United States of America: Frost & Sullivan; 2020.
|